Copyright © Inderes 2011 - present. All rights reserved.

BICO Group

17.30 SEK

-1.48 %

Less than 1K followers

BICO

NASDAQ Stockholm

Medical Equipment & Services

Health Care

-1.48 %
+1.88 %
-17.85 %
-11.78 %
-22.77 %
-56.22 %
-74.45 %
-95.45 %
+26.97 %

BICO Group operates in the biotechnology industry and focuses on the development and manufacturing of technologies for cell-based research and medical development. The company's products are aimed at researchers and pharmaceutical companies. The business is global with a main presence in Europe, North America and Asia. BICO Group was founded in 2016 and is headquartered in Gothenburg, Sweden.

Read more
Market cap
1.22B SEK
Turnover
120.09K SEK
Revenue
1.5B
EBIT %
-86.33 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
29/4
2026

Interim report Q1'26

7/5
2026

General meeting '26

19/8
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
Let’s revive this thread again. Bico’s 2024 results are out, and after a couple of years in the wilderness, things actually look quite good. Losses have significantly decreased from 2023, and Q4/2024 has been a profitable quarter. Source: https://bico.com/investors/ If anyone is ...
2/21/2025, 9:55 AM
by Karibu
7
Tässä ABG:n tuoreesta rapsasta pääkohdat. Target laskettu 35 SEK (210) ja suositus laskettu HOLD (BUY). Preliminary Q2 figures and credit provision Preliminary Q2 sales were SEK 543m (-9% vs ABGSCe 594m) and EBITDA was SEK -20m (-165% vs ABGSCe SEK 31m). The organic growth was 9%...
7/18/2022, 7:34 AM
by Hasbi
7
This news published in early July hadn’t been posted here yet: Next step in Sartorius partnership finalized: several sub-sales and distribution agreements as well as R&D project agreements have been signed BICO Single Press release BICO enables and automates the life science lab ...
7/19/2023, 10:29 AM
by Warren Noutopöytätarjoilu
6
Riskillä lisäilin isosti kun käytiin kolmenkympin alapuolella, heinäkuun kurssilasku tuntui niin yliampuvalta. Aika hyvä raportti ja tekemisen suunta näyttää taas erittäin hyvältä. Tätä kirjoittaessa +38% reaktio rapsaan BICO - The Bio Convergence Company Single Press release
11/9/2022, 8:58 AM
by jepukka666
6
Bico heräilee koomasta pyrähdyksittäin. Tätä kirjoitettaessa on kaikkien aikojen yhden päivän kurssinousu. Eli Sartorius ostaa 10% siivun Bicosta ja ne ovat uusia osakkeita, jotka liudentavat omistusta. Paradoksaalisesti tämä osakeanti aiheutti osakkeen kasvupyrähdyksen. On ainakin...
12/9/2022, 1:17 PM
by Karibu
5
Ja takaisin kanveesiin BICO Group AB (publ) today announces the decision to impair goodwill in Ginolis totaling SEK 625 million, ahead of the year-end report 2022 to be published on 22 February 2023. BICO - The Bio Convergence Company Single Press release BICO skapar framtiden fö...
2/21/2023, 7:07 PM
by Pohjolan Eka
3
Bico Group Audiocast Q3’25: Inderes BICO, Audiocast, Q3'25 - Inderes Time: 2025-11-04 10:00 Language: en Language: en Sector: Health care - Pharmaceuticals & Biotechnology Activity: Audiocast with teleconference
11/4/2025, 12:16 PM
by Isa Hudd
2
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.